Page 6 - Nasdaq Path News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Royal London Asset Management Ltd. purchased a new stake in UiPath Inc. (NASDAQ:PATH – Get Rating) during the 4th quarter, Holdings Channel.com reports. The fund purchased 75,455 shares of the healthcare company’s stock, valued at approximately $3,256,000. Other institutional investors also recently made changes to their positions in the company. Carroll Financial Associates Inc. purchased […]

UiPath (NASDAQ:PATH – Get Rating) had its price target cut by equities research analysts at Wells Fargo & Company from $60.00 to $45.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare company’s stock. Wells Fargo & Company‘s target price points to a potential upside of […]

Cubist Systematic Strategies LLC decreased its position in shares of UiPath Inc. (NASDAQ:PATH – Get Rating) by 83.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,608 shares of the healthcare company’s stock after selling 47,152 shares during the period. Cubist […]